These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3933343)

  • 1. Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone.
    Altman RD
    Am J Med; 1985 Nov; 79(5):583-90. PubMed ID: 3933343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective short term treatment of Paget's disease with oral etidronate.
    Preston CJ; Yates AJ; Beneton MN; Russell RG; Gray RE; Smith R; Kanis JA
    Br Med J (Clin Res Ed); 1986 Jan; 292(6513):79-80. PubMed ID: 3080099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of etidronate (EHDP) in Paget's disease of bone.
    Johnston CC; Khairi MR; Meunier PJ
    Arthritis Rheum; 1980 Oct; 23(10):1172-6. PubMed ID: 6775643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
    Ravault A; Meunier PJ
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):293-302. PubMed ID: 2496461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 7. A patient with Paget's disease of bone treated with etidronate disodium.
    Koga K; Kawasaki K; Kohno S; Yamada K; Itoh T; Nonaka K
    Kurume Med J; 1998; 45(4):345-9. PubMed ID: 9914722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
    O'Donoghue DJ; Hosking DJ
    Bone; 1987; 8(4):219-25. PubMed ID: 3128315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term therapy of Paget's disease of bone with EHDP.
    Siris ES; Canfield RE; Jacobs TP; Baquiran DC
    Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
    Roux C; Gennari C; Farrerons J; Devogelaer JP; Mulder H; Kruse HP; Picot C; Titeux L; Reginster JY; Dougados M
    Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia].
    Reginster JY; Gritten C; Diverse P; Hauwaert PC; Crielaard JM; Halleux R; Franchimont P
    Rev Rhum Mal Osteoartic; 1985 Mar; 52(3):145-50. PubMed ID: 3923603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of disodium etidronate on Paget's disease of bone.
    Muir HG; Schabort I; Hough FS
    S Afr Med J; 1987 Oct; 72(7):470-2. PubMed ID: 3116683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternate calcitonin and etidronate disodium therapy for Paget's bone disease.
    Perry HM; Droke DM; Avioli LV
    Arch Intern Med; 1984 May; 144(5):929-33. PubMed ID: 6424594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
    Meunier PJ; Chapuy MC; Delmas P; Charhon S; Edouard C; Arlot M
    Am J Med; 1987 Feb; 82(2A):71-8. PubMed ID: 3103438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
    Khairi MR; Altman RD; DeRosa GP; Zimmermann J; Schenk RK; Johnston CC
    Ann Intern Med; 1977 Dec; 87(6):656-63. PubMed ID: 412450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
    Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.